Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy.

NFkappaB TNF receptor 2 (TNFR2) TNF receptor associated factor 1 and 2 (TRAF1, TRAF2) regulatory T-cell (Treg) tumor necrosis factor (TNF)

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
25 May 2022
Historique:
received: 18 04 2022
revised: 19 05 2022
accepted: 22 05 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 11 6 2022
Statut: epublish

Résumé

Despite the great success of TNF blockers in the treatment of autoimmune diseases and the identification of TNF as a factor that influences the development of tumors in many ways, the role of TNFR2 in tumor biology and its potential suitability as a therapeutic target in cancer therapy have long been underestimated. This has been fundamentally changed with the identification of TNFR2 as a regulatory T-cell (Treg)-stimulating factor and the general clinical breakthrough of immunotherapeutic approaches. However, considering TNFR2 as a sole immunosuppressive factor in the tumor microenvironment does not go far enough. TNFR2 can also co-stimulate CD8

Identifiants

pubmed: 35681583
pii: cancers14112603
doi: 10.3390/cancers14112603
pmc: PMC9179537
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : project number 324392634 - TRR 221
Organisme : Deutsche Forschungsgemeinschaft
ID : DFG WA 1025/33-1

Références

Nat Immunol. 2011 Jul 19;12(8):695-708
pubmed: 21772278
Cell Death Dis. 2019 Sep 20;10(10):700
pubmed: 31541082
Oncogene. 2017 Mar;36(11):1487-1502
pubmed: 27869161
Nat Immunol. 2008 Dec;9(12):1371-8
pubmed: 18997794
Eur J Immunol. 1999 Jun;29(6):1785-92
pubmed: 10382740
Front Immunol. 2018 Jun 05;9:1274
pubmed: 29922294
Nature. 1997 Feb 20;385(6618):729-33
pubmed: 9034190
J Immunol. 2016 Apr 15;196(8):3385-97
pubmed: 26983789
Cancer Lett. 2018 Oct 10;434:22-32
pubmed: 29981431
Front Immunol. 2019 Aug 28;10:2040
pubmed: 31555271
Mol Cell. 2010 Apr 9;38(1):101-13
pubmed: 20385093
J Leukoc Biol. 2007 Jul;82(1):173-6
pubmed: 17510296
Cell Death Dis. 2018 Sep 11;9(9):921
pubmed: 30206205
Genes Dev. 2012 Feb 1;26(3):203-34
pubmed: 22302935
Cancer Lett. 1992 Jul 10;64(3):203-9
pubmed: 1322235
Eur Cytokine Netw. 2009 Sep;20(3):131-4
pubmed: 19825522
Int Immunopharmacol. 2017 Mar;44:143-152
pubmed: 28092866
Am J Hematol. 2014 Aug;89(8):795-802
pubmed: 24757092
Science. 2011 Oct 21;334(6054):376-80
pubmed: 22021857
Expert Opin Ther Targets. 2019 Apr;23(4):295-307
pubmed: 30856027
J Immunol. 1997 Mar 1;158(5):2398-404
pubmed: 9036990
J Clin Invest. 2014 Feb;124(2):528-42
pubmed: 24382349
Cancer Res. 2014 Nov 15;74(22):6430-40
pubmed: 25252912
Nature. 1997 Feb 20;385(6618):733-6
pubmed: 9034191
Br J Haematol. 1998 Sep;102(4):1025-34
pubmed: 9734654
Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21666-21672
pubmed: 31597740
Immun Inflamm Dis. 2014 Aug;2(2):121-30
pubmed: 25400932
Immunity. 2017 Sep 19;47(3):450-465.e5
pubmed: 28889947
Ann Transl Med. 2020 Dec;8(24):1647
pubmed: 33490159
J Cell Biol. 2008 Jul 14;182(1):171-84
pubmed: 18606850
Gastroenterology. 2017 Feb;152(3):533-545
pubmed: 28003097
Theranostics. 2020 Mar 15;10(10):4481-4489
pubmed: 32292509
Cancer Res. 2015 Dec 15;75(24):5235-47
pubmed: 26483205
Front Immunol. 2022 Feb 16;13:835690
pubmed: 35251028
Cell Death Dis. 2021 Apr 6;12(4):360
pubmed: 33824270
Cell. 2017 Sep 7;170(6):1096-1108.e13
pubmed: 28886380
Oncoimmunology. 2017 Oct 11;7(12):e1386826
pubmed: 30524877
Am J Pathol. 2007 May;170(5):1781-92
pubmed: 17456781
Sci Signal. 2020 Jan 14;13(614):
pubmed: 31937565
Cell Rep. 2017 Apr 18;19(3):584-600
pubmed: 28423321
Clin Immunol. 2013 Dec;149(3):450-63
pubmed: 24211847
Nat Metab. 2020 Oct;2(10):1046-1061
pubmed: 32958937
EMBO J. 1999 Jun 1;18(11):3034-43
pubmed: 10357816
Sci Transl Med. 2019 Oct 2;11(512):
pubmed: 31578241
J Exp Med. 2014 Jun 2;211(6):1093-108
pubmed: 24842373
Cell Res. 2011 Jan;21(1):71-85
pubmed: 21173796
Cancer Res. 2010 Oct 15;70(20):7764-75
pubmed: 20924115
Cell. 1995 Dec 1;83(5):793-802
pubmed: 8521496
Results Probl Cell Differ. 2009;49:1-15
pubmed: 19137269
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
Nat Immunol. 2014 Jun;15(6):580-587
pubmed: 24728351
J Immunol. 2001 Dec 15;167(12):6812-20
pubmed: 11739497
J Immunol. 2004 Oct 1;173(7):4433-42
pubmed: 15383574
Sci Signal. 2017 Jan 17;10(462):
pubmed: 28096513
J Cell Sci. 2002 Jul 1;115(Pt 13):2757-70
pubmed: 12077366
Oncotarget. 2016 Oct 18;7(42):68278-68291
pubmed: 27626702
Cancer Immunol Immunother. 2009 Aug;58(8):1219-28
pubmed: 19052741
Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G850-9
pubmed: 19179628
J Leukoc Biol. 2020 Jun;107(6):971-980
pubmed: 32202358
Nat Med. 1999 Jul;5(7):828-31
pubmed: 10395330
J Immunol. 2007 Jul 1;179(1):154-61
pubmed: 17579033
Clin Exp Med. 2018 Nov;18(4):547-554
pubmed: 29802567
Cancer Res. 1999 Sep 15;59(18):4516-8
pubmed: 10493498
Int Immunopharmacol. 2021 Dec;101(Pt A):108345
pubmed: 34794079
Cancer Res. 2021 Jun 1;81(11):3036-3050
pubmed: 33619115
Front Immunol. 2018 Mar 21;9:573
pubmed: 29619032
Cell. 2008 May 30;133(5):775-87
pubmed: 18510923
Front Cell Dev Biol. 2019 May 29;7:91
pubmed: 31192209
Cell Rep. 2019 Dec 24;29(13):4509-4524.e5
pubmed: 31875557
J Immunol. 2008 Mar 1;180(5):2747-51
pubmed: 18292492
Front Immunol. 2017 Nov 06;8:1482
pubmed: 29163543
Oncogene. 2021 Jun;40(22):3786-3798
pubmed: 33958724
J Immunol. 2009 Nov 15;183(10):6051-7
pubmed: 19841176
Trends Biochem Sci. 2002 Jan;27(1):19-26
pubmed: 11796220
Blood. 2014 Aug 28;124(9):1450-9
pubmed: 25037628
J Immunol. 2006 Jan 15;176(2):1026-35
pubmed: 16393990
Cells. 2021 Jun 08;10(6):
pubmed: 34201054
Front Immunol. 2018 Mar 26;9:594
pubmed: 29632537
Genes Dev. 1997 Nov 1;11(21):2810-21
pubmed: 9353251
Biochemistry. 1996 Jun 25;35(25):8216-25
pubmed: 8679576
J Immunol. 2014 Sep 15;193(6):2952-60
pubmed: 25098294
Cell Death Dis. 2016 Sep 22;7(9):e2375
pubmed: 27899821
J Transl Med. 2014 Jan 23;12:19
pubmed: 24457057
Cancer Cell. 2016 Dec 12;30(6):925-939
pubmed: 27866850
Sci Signal. 2020 Dec 08;13(661):
pubmed: 33293464
Front Immunol. 2017 Aug 25;8:999
pubmed: 28890718
Eur J Immunol. 2010 Oct;40(10):2891-901
pubmed: 21038470
Oncol Lett. 2017 Jan;13(1):342-346
pubmed: 28123565
Leukemia. 2019 May;33(5):1206-1218
pubmed: 30356161
Sci Signal. 2018 Jan 02;11(511):
pubmed: 29295954
Mol Med Rep. 2017 Sep;16(3):2962-2968
pubmed: 28677724
J Immunol. 2008 May 15;180(10):6467-71
pubmed: 18453563
Oncol Lett. 2017 Aug;14(2):2393-2398
pubmed: 28789455
Nat Immunol. 2008 Dec;9(12):1364-70
pubmed: 18997792
Cancer Immunol Immunother. 2015 Nov;64(11):1475-85
pubmed: 26280204
Protein J. 2011 Apr;30(4):281-9
pubmed: 21574063
Cell Death Dis. 2011 Aug 18;2:e194
pubmed: 21850048
J Immunol. 2000 Aug 15;165(4):2165-72
pubmed: 10925303
Cell Death Dis. 2019 Mar 4;10(3):224
pubmed: 30833543
Front Immunol. 2013 Jun 07;4:139
pubmed: 23760533
Nat Rev Cancer. 2009 Apr;9(4):274-84
pubmed: 19308067
Neoplasia. 2021 Feb;23(2):197-209
pubmed: 33383310
Eur J Immunol. 2020 Jul;50(7):972-985
pubmed: 32012260
Int J Mol Sci. 2017 Jan 19;18(1):
pubmed: 28106845
Stem Cell Res Ther. 2020 Jul 16;11(1):281
pubmed: 32669116
J Biol Chem. 2003 Dec 19;278(51):51267-76
pubmed: 14532277
Blood. 1998 Dec 1;92(11):4150-66
pubmed: 9834220
Curr Top Microbiol Immunol. 2011;344:61-95
pubmed: 20512555
Oncotarget. 2017 Jan 31;8(5):8420-8435
pubmed: 28039479
J Immunol. 2009 Apr 15;182(8):4499-506
pubmed: 19342621
Cancer Cell. 2016 Jul 11;30(1):75-91
pubmed: 27411587
Cell Commun Signal. 2020 Jun 16;18(1):94
pubmed: 32546175
Bioinformatics. 2021 May 5;37(5):669-676
pubmed: 32991680
Sci Rep. 2013 Nov 06;3:3153
pubmed: 24193319
J Leukoc Biol. 2020 Jun;107(6):981-991
pubmed: 32449229
J Clin Invest. 2012 Nov;122(11):4094-104
pubmed: 23064360
Immunity. 2015 Feb 17;42(2):227-238
pubmed: 25680271
Clin Cancer Res. 2012 Jul 1;18(13):3637-47
pubmed: 22573350
World J Stem Cells. 2021 Aug 26;13(8):971-984
pubmed: 34567420
Immunol Rev. 2010 May;235(1):105-16
pubmed: 20536558
Mol Immunol. 2021 Sep;137:52-56
pubmed: 34214829
Cell Death Differ. 2015 Nov;22(11):1727-41
pubmed: 26292758
Cell Stem Cell. 2019 Jul 3;25(1):137-148.e6
pubmed: 31031138
Blood. 2008 Jan 1;111(1):219-28
pubmed: 17885078
J Immunol. 2014 Feb 1;192(3):1320-31
pubmed: 24379122
Mol Cancer Ther. 2009 Sep;8(9):2655-63
pubmed: 19755514
Mol Cell Biol. 2002 Nov;22(21):7512-23
pubmed: 12370298
Nat Rev Immunol. 2006 Apr;6(4):295-307
pubmed: 16557261
Cancer Res. 2004 Sep 1;64(17):6337-43
pubmed: 15342423
PLoS One. 2014 Feb 10;9(2):e88369
pubmed: 24520376
Cell. 2001 Feb 23;104(4):487-501
pubmed: 11239407
EMBO J. 2005 May 18;24(10):1886-98
pubmed: 15861135
Nat Genet. 2015 Sep;47(9):1056-60
pubmed: 26258847
Immunity. 1998 Jan;8(1):21-30
pubmed: 9462508
Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034
pubmed: 20066092
J Exp Med. 2002 Aug 5;196(3):379-87
pubmed: 12163566
J Immunol. 2010 Jul 1;185(1):174-82
pubmed: 20525892
Oncogene. 2004 Mar 11;23(10):1902-10
pubmed: 14661063
Immunobiology. 2011 Dec;216(12):1256-63
pubmed: 21840621
Front Cell Dev Biol. 2020 Dec 04;8:596831
pubmed: 33344453
Sci Signal. 2010 Nov 16;3(148):ra83
pubmed: 21081755
Br J Cancer. 1998 Jun;77(12):2357-62
pubmed: 9649158
Biochem Pharmacol. 2018 Jul;153:292-298
pubmed: 29378181
Nat Commun. 2015 Jan 07;6:5930
pubmed: 25565375
J Immunol. 2000 Nov 1;165(9):4814-21
pubmed: 11046004
Oncogenesis. 2017 Sep 25;6(9):e383
pubmed: 28945218
Blood Adv. 2020 Oct 13;4(19):4823-4833
pubmed: 33027529
Cell. 1994 Aug 26;78(4):681-92
pubmed: 8069916
Clin Cancer Res. 2015 Feb 15;21(4):687-92
pubmed: 25501578
Annu Rev Immunol. 1996;14:649-83
pubmed: 8717528
Mol Cell Biol. 2012 Jul;32(13):2515-29
pubmed: 22547679
Front Immunol. 2018 Mar 22;9:583
pubmed: 29623079
Hepatology. 2007 Sep;46(3):699-705
pubmed: 17654744
Clin Immunol. 2013 Oct;149(1):97-110
pubmed: 23948613
Nat Commun. 2019 Dec 17;10(1):5745
pubmed: 31848339
Thorac Cancer. 2019 Mar;10(3):437-444
pubmed: 30628200
J Biol Chem. 2011 May 13;286(19):17015-28
pubmed: 21393245
Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10662-7
pubmed: 21670304
Br J Cancer. 2016 Apr 26;114(9):995-1002
pubmed: 27031855
Immunity. 2009 Dec 18;31(6):921-31
pubmed: 20064449
Leukemia. 2017 May;31(5):1154-1165
pubmed: 27748372
J Exp Med. 1995 Feb 1;181(2):607-17
pubmed: 7836916
Cell. 2019 Jul 25;178(3):585-599.e15
pubmed: 31303383
Front Immunol. 2018 Jan 19;8:1951
pubmed: 29403470
J Immunol. 2018 Apr 1;200(7):2362-2371
pubmed: 29459403
Oncogene. 2009 Apr 16;28(15):1769-81
pubmed: 19287455

Auteurs

Juliane Medler (J)

Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Auvera Haus, Grombühlstrasse 12, 97080 Würzburg, Germany.

Kirstin Kucka (K)

Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Auvera Haus, Grombühlstrasse 12, 97080 Würzburg, Germany.

Harald Wajant (H)

Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Auvera Haus, Grombühlstrasse 12, 97080 Würzburg, Germany.

Classifications MeSH